• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

International Alliance of ALS/MND Associations

  • Members' Login
  • Contact
  • Join the Alliance
  • Donate
  • Understanding ALS/MND
    • What is ALS/MND
    • Genetics
    • Diagnosis
    • Glossary
    • Navigating the Community
  • Find a Member Association
  • Support for PALS & CALS
    • Fundamental Rights for People with ALS/MND and Caregivers
    • Research
      • Clinical Trial Registry Accuracy and Maintenance in ALS/MND Research
      • Voice Preservation
      • Open Science
        • Open Label Extension
      • Expanded Access
      • Understanding ALS/MND Research
      • Improving Regulatory Pathways
      • Right to Try
      • US FDA Orphan Drug Designation
      • Unproven (Off-Label) Treatments
    • Advocacy
      • Advocacy Toolkit
      • Emergency Preparedness Toolkit
      • Equitable Access to Therapies
      • Recommendations for Trial Sponsors
    • Clinical Care
      • Genetic Counselling & Testing
      • Mental Health Support
      • Nursing and Symptom Management
      • Nutrition and Swallowing
      • Occupational Therapy and Activities of Daily Living
      • Physiotherapy and Mobility
      • Respiratory Care
      • Speech Therapy and Communication
      • Support for Family & Caregivers
      • Technology
      • Global Clinic Locator
    • Drugs in Development
      • Masitinib
      • NurOwn
      • CNM-Au8
      • ILB
      • AstroRx
      • Neuronata-R / Lenzumestrocel
      • PrimeC
      • NP001
      • Pridopidine
      • SOD1 Therapies and Trials
      • C9orf72 Therapies and Trials
      • SPG302
      • Regulatory T Cell Enhancing Therapies
      • Ulefnersen
    • Approved Drugs
      • Nuedexta
      • Radicava / Edaravone
      • Riluzole / Tiglutik
      • Rozebalamin / Methylcobalamin
      • Tofersen / Qalsody
    • Drugs No Longer in Development
      • AMX0035
      • Reldesemtiv
      • Arimoclomol
      • TUDCA
      • CuATSM
  • Support for Health Professionals
    • Breaking the News in ALS/MND
    • R.A.C.E. to Diagnose ALS/MND
  • Programs & Events
    • Calendar of Events
    • Global Day Calendar
    • Alliance Meeting
    • Allied Professionals Forum
    • “Day in the Life Of” Suite
    • Alliance Webinars
    • ALS/MND Connect
    • March of Faces
    • Patient Fellows Program
    • Alliance Fellows
    • SEED Grant Program
  • About
    • Who We Are
    • ALS/MND Health Literacy Map
    • Board of Trustees
    • Councils, Forums & Committees
      • Scientific Advisory Council
      • PALS and CALS Advisory Council
      • Advocacy and Public Policy Forum
      • Research Directors Forum
      • Governance Committee
      • Finance Committee
    • Staff
    • History
    • Newsletter Archive
    • Awards
      • Forbes Norris Award
      • Humanitarian Award
      • Allied Health Professional Award
      • Student Innovation Award
  • Members
    • Member Registration
    • Forgot Password

History

The International Alliance of ALS/MND Associations was founded in 1992 by a small group of national ALS/MND associations that shared a common goal: to strengthen support for people living with ALS/MND by working together across borders.

What began as a collaborative network has grown into a global community of more than 80 member associations in over 40 countries. Today, the Alliance connects organizations, healthcare professionals, researchers, people living with ALS/MND, caregivers, and advocates to improve care, advance research, and build a world free of ALS/MND.

How the Alliance Began

Based on recollections by Mavis Gallienne, Wendy Abrams, Rodney Harris, and Peter Cardy (December 2012).

The idea for an international ALS/MND network emerged in 1987–1988, shortly after Peter Cardy became Chief Executive Officer of the MND Association of England, Wales and Northern Ireland.

The Association launched an annual international research meeting — the event that would later become the International Symposium on ALS/MND. Originally titled Who Is Out There Researching Into MND?, the meeting brought together researchers and representatives from ALS/MND organizations around the world.

As these meetings grew, so did conversations about creating an international organization that could connect national associations, strengthen support for people living with ALS/MND, and encourage global research collaboration. Those discussions led to the founding of the International Alliance of ALS/MND Associations.

The Founding of the Alliance

The Alliance was formally established during a meeting held in Solihull, Birmingham, England, from November 4–6, 1992. Representatives from ALS/MND associations agreed to create an international organization dedicated to collaboration, shared learning, advocacy, and research.

Read the Official Notes from the Founding Meeting

Marking 30 Years

In 2022, the Alliance celebrated its 30th anniversary with a video reflecting on its history and the people who helped build the global ALS/MND community.

Growing a Global Community

Over the past three decades, the Alliance has evolved from a network centred on an annual meeting into a year-round global organization supporting collaboration, education, advocacy, and research.

Expanding our global reach

Membership has expanded to more than 80 organizations in over 40 countries, with increasing engagement in Latin America, Africa, South Asia, and other regions where ALS/MND services and research infrastructure continue to develop. Regional collaborations, including ALS Africa and ELATAM, have strengthened local leadership and knowledge sharing.

Creating new opportunities for collaboration

The Alliance has also launched initiatives that bring more voices into the global ALS/MND community. These include the Patient Fellows Program, which supports people living with ALS/MND and caregivers to participate in international research discussions; the Allied Professionals Forum, which connects healthcare professionals worldwide; and the SEED Grant Program, which provides early-stage funding to strengthen ALS/MND research capacity in low- and middle-income countries.

In 2025, the Alliance published the ALS/MND Health Literacy Map, a global framework that identifies the information and support people living with ALS/MND, caregivers, and families need throughout the disease journey. The framework now guides much of the Alliance’s education and communications work.

Guiding our work today

Today, the Alliance continues to unite organizations around a shared vision of a world free of ALS/MND. Its 2026–2028 Strategy focuses on improving quality of life, expanding inclusion, raising global awareness, strengthening research collaboration, building organizational capacity, and growing the international ALS/MND community.

Alliance Chairs

The following individuals have served as Chair of the International Alliance of ALS/MND Associations:

Eithne Frost
MND Association of Ireland
Mavis Gallienne
MND Australia, UK
Wendy Abrams
Les Turner ALS Foundation, USA
Diane Heron
MND Association of South Africa
Rod Harris
MND Victoria, Australia
Gudjon Sigurdsson
MND Iceland
Jeffrey Deitch
ALS Hope Foundation, USA
Carol Birks
MND Australia
Steve Bell
MND Association, UK
Calaneet Balas
The ALS Association, USA (2018–2025)
Tammy Moore
ALS Society of Canada (2025–present)

Primary Sidebar

About

  • Who We Are
  • Board of Trustees
  • Councils, Forums & Committees
    • PALS and CALS Advisory Council
    • Scientific Advisory Council
    • Advocacy and Public Policy Forum
    • Research Directors Forum
    • Governance Committee
    • Finance Committee
  • Staff
  • History
  • Newsletter Archive
    • Newsletters
    • Meetings
  • Awards

  • Marcel R. Wernard, Netherlands

    Marcel R. Wernard, Netherlands

  • Hans Dieter Olszewski, Germany

    Hans Dieter Olszewski, Germany

  • Mary Thomas, Australia

    Mary Thomas, Australia

  • Mahmood Anwar, UK

    Mahmood Anwar, UK

  • Natalya Rybakova, Russia

    Natalya Rybakova, Russia

  • Liz Ogg, Scotland

    Liz Ogg, Scotland

  • João Marcos Andrietta, Brazil

    João Marcos Andrietta, Brazil

  • Valdomiro Xavier Honório, Brazil

    Valdomiro Xavier Honório, Brazil

  • Mark Miller, UK

    Mark Miller, UK

  • Lee Millard, England

    Lee Millard, England

  • Camilla Heiberg Freiberg, Denmark

    Camilla Heiberg Freiberg, Denmark

  • Dr. Janmejay Pradhan, India

    Dr. Janmejay Pradhan, India

  • Claire Garry, USA

    Claire Garry, USA
    20200117_214643

  • Steven Gallagher, Canada

    Steven Gallagher, Canada

  • Margreth Burger-Saile, Switzerland

    Margreth Burger-Saile, Switzerland

  • Wilfried Leusing, Germany

    Wilfried Leusing, Germany

  • Carlos Alberto Arango, Colombia

    Carlos Alberto Arango, Colombia

  • Jason Goodman, USA

    Jason Goodman, USA

  • Monica Soriano, Argentina

    Monica Soriano, Argentina

  • Lachlan Terry, Australia

    Lachlan Terry, Australia

  • Maria Lucia Wood Saldanha, Brazil

    Maria Lucia Wood Saldanha, Brazil

  • Chun Ju Xiao, China

    Chun Ju Xiao, China

  • Aida Trzmiel de Guterman, Argentina

    Aida Trzmiel de Guterman, Argentina

  • Xian-Zhang Niu, China

    Xian-Zhang Niu, China

  • Alfredo Santos, Colombia

    Alfredo Santos, Colombia

  • Wendy Hendrickson, USA

    Wendy Hendrickson, USA

  • Richard Clark, New Zealand

    Richard Clark, New Zealand

  • Fernando Ocampo Cardona, Colombia

    Fernando Ocampo Cardona, Colombia

  • Carlos Alberto Báez Murillo, Colombia

    Carlos Alberto Báez Murillo, Colombia

  • Brian Lovell, Australia

    Brian Lovell, Australia

  • Jorge Luis Fernández Romero, Mexico

    Jorge Luis Fernández Romero, Mexico

  • Motoko Ogasawara, Japan

    Motoko Ogasawara, Japan

  • Liam Dwyer, England

    Liam Dwyer, England

  • Den Haag, Netherlands

    Den Haag, Netherlands

  • Conny van der Meijden, Netherlands

    Conny van der Meijden, Netherlands

  • Zabun Nassar, England

    Zabun Nassar, England

  • Francisco Perez Palop, Spain

    Francisco Perez Palop, Spain

  • Vincent Bourque, Canada

    Vincent Bourque, Canada
    vincent_bourque

  • Steve Lufkin, USA

    Steve Lufkin, USA
    IMG_3993

  • Ali Var, Turkey

    Ali Var, Turkey

  • Greg Heydet, USA

    Greg Heydet, USA

  • Feng Gin Sun, China

    Feng Gin Sun, China

  • Elkin Gaviria, Colombia

    Elkin Gaviria, Colombia

  • Shay Rishoni, Netherlands

    Shay Rishoni, Netherlands

  • Art Eggert, USA

    Art Eggert, USA

  • Duncan Bayly, Australia

    Duncan Bayly, Australia

  • Chirag Walia, India

    Chirag Walia, India
    ChiragWalia

  • JP

    JP

  • Gudjon Sigurdsson, Iceland

    Gudjon Sigurdsson, Iceland

  • Jean Waters, UK

    Jean Waters, UK

Learn more about the March of Faces

Footer

Stay connected to the global ALS/MND community.

Subscribe to receive our newsletter and updates on how to get involved across the Alliance network.

 
This field is for validation purposes and should be left unchanged.
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube
Return to top of page

Contact | Disclaimer | Privacy Notice & Cookies | Sitemap

Copyright © 2026 The International Alliance of ALS/MND Associations. All rights reserved.


Registered in England: Charity Number 1079504 · Site built by graphics.coop · Powered by WordPress · Members' login